View in EDS HTML Full Text PDF Full Text

Budget impact of maternal vaccination with RSVpreF to protect privately insured infants in Dubai against respiratory syncytial virus.

Saved in:
Bibliographic Details
Title: Budget impact of maternal vaccination with RSVpreF to protect privately insured infants in Dubai against respiratory syncytial virus.
Authors: Zayed M; Access and Value Department, Pfizer Gulf FZ LLC, Dubai, United Arab Emirates., Joury J; Medical Affairs Department, Pfizer Gulf FZ LLC, Dubai, United Arab Emirates., Farghaly M; Health Economics & Insurance Policies Department, Dubai Health Authority, Dubai, United Arab Emirates., Al Dallal S; Strategy and Governance Department, Dubai Health Authority, Dubai, United Arab Emirates., Mahendiran R; Real World Evidence Department, IQVIA, Bengaluru, India., Law AW; HTA, Value & Evidence Department, Pfizer Inc, New York, NY, USA., Mendes D; HTA, Value & Evidence Department, Pfizer Ltd, Tadworth, UK., Quinn E; Avalere Health, Washington, DC, USA., Kutrieb E; Avalere Health, Washington, DC, USA., Averin A; Avalere Health, Washington, DC, USA.
Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2025 Dec; Vol. 21 (1), pp. 2523106. Date of Electronic Publication: 2025 Jul 02.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40600492
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Budget impact of maternal vaccination with RSVpreF to protect privately insured infants in Dubai against respiratory syncytial virus.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zayed+M%22">Zayed M</searchLink>; Access and Value Department, Pfizer Gulf FZ LLC, Dubai, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Joury+J%22">Joury J</searchLink>; Medical Affairs Department, Pfizer Gulf FZ LLC, Dubai, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Farghaly+M%22">Farghaly M</searchLink>; Health Economics & Insurance Policies Department, Dubai Health Authority, Dubai, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Al+Dallal+S%22">Al Dallal S</searchLink>; Strategy and Governance Department, Dubai Health Authority, Dubai, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Mahendiran+R%22">Mahendiran R</searchLink>; Real World Evidence Department, IQVIA, Bengaluru, India.<br /><searchLink fieldCode="AU" term="%22Law+AW%22">Law AW</searchLink>; HTA, Value & Evidence Department, Pfizer Inc, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Mendes+D%22">Mendes D</searchLink>; HTA, Value & Evidence Department, Pfizer Ltd, Tadworth, UK.<br /><searchLink fieldCode="AU" term="%22Quinn+E%22">Quinn E</searchLink>; Avalere Health, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Kutrieb+E%22">Kutrieb E</searchLink>; Avalere Health, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Averin+A%22">Averin A</searchLink>; Avalere Health, Washington, DC, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101572652%22">Human vaccines & immunotherapeutics</searchLink> [Hum Vaccin Immunother] 2025 Dec; Vol. 21 (1), pp. 2523106. <i>Date of Electronic Publication: </i>2025 Jul 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572652 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2164-554X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221645515%22">21645515 </searchLink><i>NLM ISO Abbreviation: </i>Hum Vaccin Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40600492
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/21645515.2025.2523106
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2523106
    Titles:
      – TitleFull: Budget impact of maternal vaccination with RSVpreF to protect privately insured infants in Dubai against respiratory syncytial virus.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zayed M
      – PersonEntity:
          Name:
            NameFull: Joury J
      – PersonEntity:
          Name:
            NameFull: Farghaly M
      – PersonEntity:
          Name:
            NameFull: Al Dallal S
      – PersonEntity:
          Name:
            NameFull: Mahendiran R
      – PersonEntity:
          Name:
            NameFull: Law AW
      – PersonEntity:
          Name:
            NameFull: Mendes D
      – PersonEntity:
          Name:
            NameFull: Quinn E
      – PersonEntity:
          Name:
            NameFull: Kutrieb E
      – PersonEntity:
          Name:
            NameFull: Averin A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2164-554X
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Human vaccines & immunotherapeutics
              Type: main
ResultId 1